tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results
Company AnnouncementsBriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results
2d ago
BCTX
BriaCell issues letter to shareholders
PremiumThe Fly
BriaCell issues letter to shareholders
2d ago
BCTX
BriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
PremiumCompany Announcements
BriaCell’s Phase 3 Data Shows Promise for Metastatic Breast Cancer Treatment
22d ago
BCTX
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
PremiumThe Fly
BriaCell presents preclinical data from Phase 3 study of Bria-IMT
22d ago
BCTX
BriaCell Therapeutics Closes $13.8 Million Public Offering
PremiumCompany Announcements
BriaCell Therapeutics Closes $13.8 Million Public Offering
24d ago
BCTX
BriaCell’s Breakthrough in Cancer Immunotherapy at AACR 2025
PremiumCompany AnnouncementsBriaCell’s Breakthrough in Cancer Immunotherapy at AACR 2025
24d ago
BCTX
BriaCell presents data from Phase 2 study of Bria-IMT
Premium
The Fly
BriaCell presents data from Phase 2 study of Bria-IMT
24d ago
BCTX
BriaCell 3.07M share Secondary priced at $4.50
Premium
The Fly
BriaCell 3.07M share Secondary priced at $4.50
28d ago
BCTX
BriaCell Therapeutics Announces $13.8 Million Public Offering
PremiumCompany Announcements
BriaCell Therapeutics Announces $13.8 Million Public Offering
28d ago
BCTX
BriaCell’s Bria-OTS Shows Promising Results in Metastatic Breast Cancer Study
PremiumCompany Announcements
BriaCell’s Bria-OTS Shows Promising Results in Metastatic Breast Cancer Study
28d ago
BCTX
BriaCell confirms 100% resolution of lung metastasis with Bria-OTS
PremiumThe Fly
BriaCell confirms 100% resolution of lung metastasis with Bria-OTS
28d ago
BCTX
BriaCell to Present Key Clinical Data at ASCO 2025
PremiumCompany Announcements
BriaCell to Present Key Clinical Data at ASCO 2025
29d ago
BCTX
BriaCell files to sell 2.33M common units
PremiumThe FlyBriaCell files to sell 2.33M common units
30d ago
BCTX
BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating
Premium
Ratings
BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating
1M ago
BCTX
BriaCell Advances Phase 3 Study in Metastatic Breast Cancer
Premium
Company Announcements
BriaCell Advances Phase 3 Study in Metastatic Breast Cancer
1M ago
BCTX
BriaCell announces ongoing Phase 3 study enrolled over 75 patients
PremiumThe Fly
BriaCell announces ongoing Phase 3 study enrolled over 75 patients
1M ago
BCTX
BriaCell’s Phase 2 Study Shows Promising Survival Data in Breast Cancer
PremiumCompany Announcements
BriaCell’s Phase 2 Study Shows Promising Survival Data in Breast Cancer
1M ago
BCTX
BriaCell announces survival data from its Phase 2 study of Bria-IMT
PremiumThe Fly
BriaCell announces survival data from its Phase 2 study of Bria-IMT
1M ago
BCTX
BriaPro Advances Novel Anti-Cancer Antibody Development
PremiumCompany Announcements
BriaPro Advances Novel Anti-Cancer Antibody Development
1M ago
BCTX
BriaCell’s BriaPro develops antibodies to anti-cancer target B7-H3
PremiumThe FlyBriaCell’s BriaPro develops antibodies to anti-cancer target B7-H3
1M ago
BCTX
BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025
Premium
Company Announcements
BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025
2M ago
BCTX
BriaCell’s Phase 3 Metastatic Breast Cancer Study Receives Positive DSMB Review
Premium
Company Announcements
BriaCell’s Phase 3 Metastatic Breast Cancer Study Receives Positive DSMB Review
2M ago
BCTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >